SPE Covenant. The Seller shall not take any action that would cause a violation of [Section 7.4] of the Indenture by the Purchaser.

Confidentiality Covenant. During Employee's employment with the Company and following the termination of Employee' s employment:

Exclusivity Covenant. Subject to [Section 2.8(b)] (HFB Change of Control), [Section 2.8(c)] ([[FibroGen:Organization]] Change of Control) and [Section 2.8(d)] (Acquisition by Either Party), during the Term, the Parties will not, and will ensure that its Affiliates do not, independently, or for or with any Third Party, directly or indirectly, Develop, Manufacture, or Commercialize any Competitive Product in the Territory (or license or otherwise authorize any Third Party to do any of the foregoing) (the “Competitive Activities”) unless agreed in writing by the Parties.

Milestone Covenant. Each Credit Party shall, and shall cause each of its Subsidiaries to, as applicable, satisfy the requirements set forth below on or before the respective date specified for each such requirement (the “Milestones”):

ECI Covenant. The Company shall hold no assets other than the shares of stock of Chinos and J.Crew, ownership interests in BD Holdco, cash and any other assets incidental thereto. Notwithstanding anything in this Agreement [[Organization B:Organization]] contrary, the Company shall avoid taking any action that could cause the Company to be engaged in a trade or business in the United States within the meaning of Code [Section 864] and the Regulations promulgated thereunder. In addition, the Company will not, directly or indirectly, purchase, acquire or otherwise be treated as the owner of a Prohibited Asset.

Noncompetition Covenant. During the Term of this Agreement, Executive will not, directly or indirectly, whether as owner, partner, shareholder, consultant, agent, employee, co-venturer, lender or creditor or otherwise, engage, participate, assist, support or invest in any Competing Business.

Negative Covenant. Apollomics covenants that it will not, and will not permit any of its Affiliates or sublicensees to, use or practice any [[GlycoMimetics:Organization]] Technology outside the scope of the licenses granted to it under Sections 2.1(a) and 2.1(b).

Beginning with the month ending ​ and for each month ending thereafter, Net Revenue for the trailing six-month period ending on each such date shall equal at least ​ of the Projected Net Revenue for such applicable six-month period. Parent shall provide Agent with such information as Agent may reasonably require in connection with its testing of this financial covenant.

Financial Covenant. The Borrower shall not permit the Debt to Capitalization Ratio as of, and determined as of, the last day of each fiscal quarter and expressed as a percentage, to exceed 50%.

Financial Covenant. Maintain at all times, subject to periodic reporting as of the last day of each month, an Adjusted Quick Ratio of at least 1.25 to 1.00.